Recursion Pharmaceuticals (RXRX) Earnings Date & Reports
A.I. Advisor
published Earnings
RXRX is expected to report earnings to fall 15.00% to -34 cents per share on November 06
Q3'24
Est.
$-0.34
Q2'24
Missed
by $0.02
Q1'24
Beat
by $0.03
Q4'23
Beat
by $0.04
Q3'23
Missed
by $0.04
The last earnings report on August 08 showed earnings per share of -40 cents, missing the estimate of -38 cents. With 3.62M shares outstanding, the current market capitalization sits at 1.97B.